Seys E , Andrini O , Keck M , Mansour-Hendili L , Courand PY , Simian C , Deschenes G , Kwon T , Bertholet-Thomas A , Bobrie G , Borde JS , Bourdat-Michel G , Decramer S , Cailliez M , Krug P , Cozette P , Delbet JD , Dubourg L , Chaveau D , Fila M , Jourde-Chiche N , Knebelmann B , Lavocat MP , Lemoine S , Djeddi D , Llanas B , Louillet F , Merieau E , Mileva M , Mota-Vieira L , Mousson C , Nobili F , Novo R , Roussey-Kesler G , Vrillon I , Walsh SB , Teulon J , Blanchard A , Vargas-Poussou R .

             renal absorption

Akil, A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis. 2010, Pubmed

Akil, A patient with Bartter syndrome accompanying severe growth hormone deficiency and focal segmental glomerulosclerosis. 2010, Pubmed
Andrini, ClC-K chloride channels: emerging pathophysiology of Bartter syndrome type 3. 2015, Pubmed
Andrini, CLCNKB mutations causing mild Bartter syndrome profoundly alter the pH and Ca2+ dependence of ClC-Kb channels. 2014, Pubmed
BARTTER, Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome. 1962, Pubmed
Bacchetta, The consequences of chronic kidney disease on bone metabolism and growth in children. 2012, Pubmed
Bettinelli, Patients with biallelic mutations in the chloride channel gene CLCNKB: long-term management and outcome. 2007, Pubmed
Birkenhäger, Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. 2001, Pubmed
Blethen, Reversal of Bartter's syndrome by renal transplantation in a child with focal, segmental glomerular sclerosis. 1985, Pubmed
Boer, Bartter's syndrome with impairment of growth hormone secretion. 1992, Pubmed
Brochard, Phenotype-genotype correlation in antenatal and neonatal variants of Bartter syndrome. 2009, Pubmed
Bulucu, Association of Gitelman's syndrome and focal glomerulosclerosis. 1998, Pubmed
Buyukcelik, Bartter syndrome and growth hormone deficiency: three cases. 2012, Pubmed
Cho, Translational read-through of a nonsense mutation causing Bartter syndrome. 2013, Pubmed
Flyvbjerg, Evidence that potassium deficiency induces growth retardation through reduced circulating levels of growth hormone and insulin-like growth factor I. 1991, Pubmed
García Castaño, Genetics of type III Bartter syndrome in Spain, proposed diagnostic algorithm. 2013, Pubmed
Grill, Salt-losing nephropathy in mice with a null mutation of the Clcnk2 gene. 2016, Pubmed
Hanevold, C1q nephropathy in association with Gitelman syndrome: a case report. 2006, Pubmed
Hennings, The ClC-K2 Chloride Channel Is Critical for Salt Handling in the Distal Nephron. 2017, Pubmed
Hochberg, Growth hormone (GH) receptor and GH-binding protein deficiency in the growth failure of potassium-depleted rats. 1995, Pubmed
Houdayer, Comprehensive screening for constitutional RB1 mutations by DHPLC and QMPSF. 2004, Pubmed
Imbrici, Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery. 2016, Pubmed
Jeck, Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitelman phenotype. 2000, Pubmed
Jeck, The diuretic- and Bartter-like salt-losing tubulopathies. 2000, Pubmed
Keck, Novel CLCNKB mutations causing Bartter syndrome affect channel surface expression. 2013, Pubmed , Xenbase
Kobayashi, Human CLC-KB gene promoter drives the EGFP expression in the specific distal nephron segments and inner ear. 2002, Pubmed
Konrad, Mutations in the chloride channel gene CLCNKB as a cause of classic Bartter syndrome. 2000, Pubmed
Lan, TGF-β/Smad signaling in kidney disease. 2012, Pubmed
Lee, Renal transplantation in a patient with Bartter syndrome and glomerulosclerosis. 2011, Pubmed
Nozu, Molecular analysis of patients with type III Bartter syndrome: picking up large heterozygous deletions with semiquantitative PCR. 2007, Pubmed
Peters, Clinical presentation of genetically defined patients with hypokalemic salt-losing tubulopathies. 2002, Pubmed
Rodríguez-Soriano, Bartter and related syndromes: the puzzle is almost solved. 1998, Pubmed
Schlingmann, Salt wasting and deafness resulting from mutations in two chloride channels. 2004, Pubmed , Xenbase
Seyberth, Bartter- and Gitelman-like syndromes: salt-losing tubulopathies with loop or DCT defects. 2011, Pubmed
Simon, Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K+ channel, ROMK. 1996, Pubmed
Simon, Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. 1997, Pubmed
Simon, Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. 1996, Pubmed
Simon, Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. 1996, Pubmed
Stölting, Carboxyl-terminal Truncations of ClC-Kb Abolish Channel Activation by Barttin Via Modified Common Gating and Trafficking. 2015, Pubmed
Teulon, Exploration of the basolateral chloride channels in the renal tubule using. 2005, Pubmed
Vargas-Poussou, Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. 2002, Pubmed
Vargas-Poussou, Spectrum of mutations in Gitelman syndrome. 2011, Pubmed
Watanabe, Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. 2002, Pubmed
Yokoyama, [Endocrinological analysis before and after living-related renal transplantation in a patient of Bartter's syndrome]. 1995, Pubmed
Zelikovic, A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. 2003, Pubmed